Header Logo

Connection

Mark Pollack to Clinical Trials, Phase III as Topic

Back to Details
This is a "connection" page, showing publications Mark Pollack has written about Clinical Trials, Phase III as Topic.
Mark Pollack
Connection Strength
0.082
Clinical Trials, Phase III as Topic
  1. Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-blind, placebo-controlled, parallel-group studies. J Clin Psychopharmacol. 2008 Jun; 28(3):308-16.
    View in: PubMed
    Score: 0.082
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.